--- title: "AYJK released its 2024 annual performance, with a net profit attributable to the parent company of 40.5619 million yuan, a year-on-year decrease of 18.36%" type: "News" locale: "en" url: "https://longbridge.com/en/news/235864896.md" description: "AYJK released its 2024 annual report, with operating revenue of 2.01 billion yuan, a year-on-year decrease of 7.54%; net profit attributable to the parent company was 40.5619 million yuan, a year-on-year decrease of 18.36%. The net profit after deducting non-recurring gains and losses was 32.5767 million yuan, a year-on-year increase of 19.35%. The basic earnings per share were 0.05 yuan" datetime: "2025-04-14T11:58:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/235864896.md) - [en](https://longbridge.com/en/news/235864896.md) - [zh-HK](https://longbridge.com/zh-HK/news/235864896.md) generator: "portal-rs" --- # AYJK released its 2024 annual performance, with a net profit attributable to the parent company of 40.5619 million yuan, a year-on-year decrease of 18.36% According to the Zhitong Finance APP, AYJK (002172.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 2.01 billion yuan, a year-on-year decrease of 7.54%. The net profit attributable to shareholders of the listed company was 40.5619 million yuan, a year-on-year decrease of 18.36%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 32.5767 million yuan, a year-on-year increase of 19.35%. The basic earnings per share were 0.05 yuan ### Related Stocks - [002172.CN](https://longbridge.com/en/quote/002172.CN.md) ## Related News & Research - [FPX Nickel attends Canada Investment Summit as Baptiste project lands in investor prospectus](https://longbridge.com/en/news/298582381.md) - [Indah Prakasa Sentosa controller PT Graha Inti Guna Persada cuts stake to 79.02% from 87.48%](https://longbridge.com/en/news/298416732.md) - [Predictiv AI qualifies for Canada federal AI Source List across Bands 1-3](https://longbridge.com/en/news/298409198.md) - [Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2](https://longbridge.com/en/news/298452346.md) - [Resverlogix says new journal studies link apabetalone to lower heart-failure risk](https://longbridge.com/en/news/298584507.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**